
Cost-Effectiveness Analysis of Serplulimab Combined with Nab-Paclitaxel Plus Carboplatin Compared to Nab-Paclitaxel Plus ...
Introduction Lung cancer is the most common and deadliest cancer worldwide.1 In 2022, there were 870,982 diagnosed lung cancer cases and 766,898 lung cancer-related deaths in China.2 Non-small cell lung cancer (NSCLC) accounts for the majority (80% - 85%) …